Home - Products - Chromatin/Epigenetic - Epigenetic Reader Domain - CCT077791

CCT077791

CAS No. 748777-47-1

CCT077791( —— )

Catalog No. M34060 CAS No. 748777-47-1

CCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
25MG	1398	Get Quote
50MG	1822	Get Quote
100MG	2250	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

CCT077791
Note

Research use only, not for human use.
Brief Description

CCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
Description

CCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Chromatin/Epigenetic
Target

Epigenetic Reader Domain
Recptor

Epigenetic Reader Domain | Histone Acetyltransferase
Research Area

——
Indication

——

Chemical Information

CAS Number

748777-47-1
Formula Weight

256.67
Molecular Formula

C9H5ClN2O3S
Purity

>98% (HPLC)
Solubility

——
SMILES

O=C1N(SC(Cl)=C1)C2=CC=C(N(=O)=O)C=C2
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

ZEN-3219

ZEN-3219 is a BET inhibitor, which has inhibitory effect on BRD4(BD1), BRD4(BD2) and BRD4(BD1BD2).
FHD-286

FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
BY27

BY27, a potent and selective BET BD2 inhibitor (Ki: 3.1 nM) with anticancer activity, inhibits BD1/BD2 of BRD2, BRD3, BRD4, and BRDT, and suppresses tumor growth.

Sign In Join Free